Eden Research (LON:EDEN) Trading Down 3.3% – Here’s What Happened

Posted by Lisa Pomrenke on Feb 23rd, 2025

Shares of Eden Research plc (LON:EDEN – Get Free Report) dropped 3.3% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company’s fifty day simple moving average is GBX 3.87 and its 200 day simple moving average is GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling

In other news, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the firm’s stock in a transaction on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). 14.02% of the stock is currently owned by insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.